Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
3.200
-0.020 (-0.62%)
At close: Aug 14, 2026, 4:00 PM EDT
3.190
-0.010 (-0.31%)
After-hours: Aug 14, 2026, 7:16 PM EDT

Silo Pharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.070.070.070.070.070.07
Revenue Growth
0%0%0%0%1.18%-
Gross Profit
0.010.030.070.070.070.07
Operating Income
-4.78-4.28-4.71-3.86-3.65-2.89
Net Income
-4.84-4.23-4.39-3.7-3.912.5
Earnings Per Share
-6.80-7.57-17.90-18.02-25.6719.52
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
6.036.867.087.6711.3710.26
Total Debt
------
Net Cash (Debt)
6.036.867.087.6711.3710.26
Net Cash Growth
10.65%-3.13%-7.63%-32.58%10.85%824.31%
Net Cash Per Share
8.4712.2728.8637.3374.6680.20

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-3.84-4.66-3.83-3.22-3.5-2.28
Free Cash Flow
-3.84-4.66-3.83-3.22-3.5-2.28
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
11.90%38.57%91.90%91.90%91.90%92.98%
Operating Margin
-6631.16%-5936.95%-6526.44%-5347.41%-5059.02%-4059.33%
Pretax Margin
-6717.40%-5863.50%-6092.59%-5036.04%-5419.25%5868.30%
Profit Margin
-6717.40%-5863.50%-6092.59%-5132.57%-5420.86%3507.72%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----5.63
PS Ratio
74.1262.8055.3560.50146.27197.30